Hortilano, Pedro A.

HRN: 29-26-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/03/2026
07/09/2026
PO
5ml
QID
Oral Candidiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTIEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: